Overview

Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study will compare repeated intermittent IV dosing of diclofenac in patients with moderate to severe post-surgical pain from abdominal or pelvic surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Javelin Pharmaceuticals
Treatments:
Diclofenac
Ketorolac
Ketorolac Tromethamine